NO20073823L - Kinolinderivater for behandlingen av latent tuberkulose - Google Patents
Kinolinderivater for behandlingen av latent tuberkuloseInfo
- Publication number
- NO20073823L NO20073823L NO20073823A NO20073823A NO20073823L NO 20073823 L NO20073823 L NO 20073823L NO 20073823 A NO20073823 A NO 20073823A NO 20073823 A NO20073823 A NO 20073823A NO 20073823 L NO20073823 L NO 20073823L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- hydrogen
- het
- alkyloxy
- alkylthio
- Prior art date
Links
- 206010065048 Latent tuberculosis Diseases 0.000 title abstract 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical class N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 9
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 6
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000004414 alkyl thio group Chemical group 0.000 abstract 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 2
- 125000006350 alkyl thio alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 cyano, hydroxy Chemical group 0.000 abstract 2
- 125000001188 haloalkyl group Chemical group 0.000 abstract 2
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Anvendelse av en forbindelse med formel (Ia) eller (Ib) for fremstillingen av et medikament for behandlingen av latent tuberkulose, hvori forbindelsen med formel (Ia) eller (Ib) er (Ia) (Ib) et farmasøytisk akseptabelt salt, et kvaternært amin, et N-oksid, en tautomer form eller en stereokjemisk isomer form derav hvori R1 er hydrogen, halo, haloalkyl, cyano, hydroksy, Ar, Het, alkyl, alkyloksy, alkyltio, alkyloksyalkyl, alkyltioalkyl, Ar-alkyl eller di(Ar)alkyl; p er 1, 2, 3 eller 4; R2 er hydrogen, hydroksy, merkapto, alkyloksy, alkyloksyalkyloksy, alkyltio, mono eller di(alkyl)amino eller et radikal med formel ; R3 er alkyl, Ar, Ar-alkyl, Het eller Het-alkyl; q er null, 1, 2, 3 eller 4; R4 og R5 er hver uavhengig hydrogen, alkyl eller benzyl; eller R4 og R5 kan tas sammen inklusive N til hvilket de er bundet; R6 er hydrogen, halo, haloalkyl, hydroksy, Ar, alkyl, alkyloksy, alkyltio, alkyloksyalkyl, alkyltioalkyl, Ar-alkyl eller di(Ar)alkyl; eller to vicinale R6-radikaler kan tas sammen for å danne et bivalent radikal -CH=CH-CH=CH-; r er 1, 2, 3, 4 eller 5; R7 er hydrogen, alkyl, Ar eller Het; R8 er hydrogen eller alkyl; R9 er okso; eller R8 og R9 danner sammen radikalet =N-CH=CH- . ?? ?? ?? ?? 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04078529 | 2004-12-24 | ||
| EP05105008 | 2005-06-08 | ||
| PCT/EP2005/056594 WO2006067048A1 (en) | 2004-12-24 | 2005-12-08 | Quinoline derivatives for the treatment of latent tuberculosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20073823L true NO20073823L (no) | 2007-07-23 |
| NO340376B1 NO340376B1 (no) | 2017-04-10 |
Family
ID=35717702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20073823A NO340376B1 (no) | 2004-12-24 | 2007-07-23 | Kinolinderivater for behandlingen av latent tuberkulose |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US20060142279A1 (no) |
| EP (1) | EP1830850B1 (no) |
| CN (1) | CN103142595B (no) |
| AP (1) | AP2327A (no) |
| AR (1) | AR051790A1 (no) |
| AT (1) | ATE501721T1 (no) |
| AU (1) | AU2005242138B2 (no) |
| BR (1) | BRPI0506400B8 (no) |
| CA (1) | CA2529265C (no) |
| CR (1) | CR9267A (no) |
| CY (1) | CY1112247T1 (no) |
| DE (1) | DE602005026984D1 (no) |
| DK (1) | DK1830850T3 (no) |
| EE (1) | EE05394B1 (no) |
| HR (1) | HRP20110392T1 (no) |
| IL (1) | IL184123A (no) |
| LV (1) | LV13469B (no) |
| ME (1) | ME01207B (no) |
| MY (1) | MY145845A (no) |
| NI (1) | NI200700146A (no) |
| NO (1) | NO340376B1 (no) |
| NZ (1) | NZ555460A (no) |
| PA (1) | PA8654801A1 (no) |
| PL (1) | PL1830850T3 (no) |
| PT (1) | PT1830850E (no) |
| RS (1) | RS51730B (no) |
| SI (1) | SI1830850T1 (no) |
| TR (1) | TR200504892A1 (no) |
| TW (1) | TWI404535B (no) |
| WO (1) | WO2006067048A1 (no) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO342701B1 (no) * | 2005-06-28 | 2018-07-09 | Janssen Pharmaceutica Nv | Kinolinderivater som antibakterielle midler |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1527050T1 (sl) * | 2002-07-25 | 2010-08-31 | Janssen Pharmaceutica Nv | Kinolinski derivati in njihova uporaba kot mikobakterijski inhibitorji |
| JO3270B1 (ar) * | 2005-06-28 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات كوينولين بصفة عوامل مضادة للبكتيريا |
| KR101329587B1 (ko) * | 2005-06-28 | 2013-11-15 | 얀센 파마슈티카 엔.브이. | 항균제로서의 퀴놀린 유도체 |
| JO2970B1 (en) * | 2006-12-06 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| JO3271B1 (ar) | 2006-12-06 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات الكوينولين المضادة للجراثيم |
| JO2725B1 (en) * | 2006-12-06 | 2013-09-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| JO2683B1 (en) * | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| US20110059948A1 (en) * | 2008-01-14 | 2011-03-10 | Jyoti Chattopadhyaya | Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivatives as anti-mycobacterial agents |
| RU2404971C2 (ru) * | 2008-12-02 | 2010-11-27 | ЗАО "Фарм-Синтез" | Новые производные хинолина, способ их получения, их применение для лечения микобактериальных инфекций, фармацевтическая композиция на их основе |
| CA2751892A1 (en) | 2009-01-15 | 2010-07-22 | Rutgers, The State University Of New Jersey | Benzo [c] phenanthridines as antimicrobial agents |
| CA2760526A1 (en) | 2009-04-30 | 2010-11-04 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| US8933096B2 (en) | 2010-06-09 | 2015-01-13 | Rugers, The State University of New Jersey | Antimicrobial agents |
| WO2011163610A2 (en) * | 2010-06-25 | 2011-12-29 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| WO2013106756A2 (en) | 2012-01-13 | 2013-07-18 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| EP2828245A1 (en) | 2012-03-21 | 2015-01-28 | Rutgers, The State University of New Jersey | Antimicrobial agents |
| ES2576491T3 (es) | 2012-04-27 | 2016-07-07 | Janssen Pharmaceutica, N.V. | Derivados de quinolina antibacterianos |
| AU2013254670B2 (en) | 2012-04-27 | 2017-03-30 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
| US9458150B2 (en) | 2013-11-08 | 2016-10-04 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| KR102631986B1 (ko) | 2015-01-27 | 2024-01-30 | 얀센 파마슈티카 엔브이 | 분산성 조성물 |
| WO2017147316A1 (en) | 2016-02-25 | 2017-08-31 | Taxis Pharmaceuticals, Inc. | Synthetic processes and intermediates |
| EA201891644A1 (ru) * | 2016-03-07 | 2019-04-30 | Зе Глобал Эллайенс Фо Тб Драг Девелопмент, Инк. | Антибактериальные соединения и их применение |
| RU2629369C1 (ru) * | 2016-10-05 | 2017-08-29 | Федеральное Государственное Унитарное Предприятие "Государственный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Химических Реактивов И Особо Чистых Химических Веществ" | Четвертичные аммонийные производные 2-аминотиофен-3-карбоксилатов, обладающие противотуберкулезной активностью |
| CN110891566B (zh) | 2017-03-30 | 2023-12-19 | 塔克西斯医药股份有限公司 | 合成方法和合成中间体 |
| AU2018298855B2 (en) | 2017-07-14 | 2024-07-18 | Janssen Pharmaceutica Nv | Long-acting formulations |
| RU2661151C1 (ru) * | 2017-12-14 | 2018-07-12 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Селективные ингибиторы глицеральдегид-3-фосфатдегидрогеназы микобактерий |
| CN122320982A (zh) | 2019-01-09 | 2026-07-03 | 詹森药业有限公司 | 治疗非结核分枝杆菌疾病的组合 |
| JP2023533014A (ja) | 2020-07-09 | 2023-08-01 | ヤンセン ファーマシューティカ エヌ.ベー. | 長時間作用型配合物 |
| CA3182854A1 (en) | 2020-07-09 | 2022-01-13 | Rene Holm | Long-acting formulations |
| TW202233168A (zh) | 2020-11-12 | 2022-09-01 | 比利時商健生藥品公司 | 治療非結核分枝桿菌疾病的藥物組分之組合 |
| WO2023232838A1 (en) | 2022-05-31 | 2023-12-07 | Janssen Pharmaceutica Nv | Bedaquiline for use in the treatment of leprosy |
| WO2024068693A1 (en) | 2022-09-28 | 2024-04-04 | Janssen Pharmaceutica Nv | Long-acting formulations |
| TW202423427A (zh) | 2022-09-28 | 2024-06-16 | 比利時商健生藥品公司 | 長效配方 |
| WO2025068448A1 (en) | 2023-09-28 | 2025-04-03 | Janssen Pharmaceutica Nv | Atp synthase inhibitors for use in the treatment of non-tuberculosis mycobacteria |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR038536A1 (es) * | 2002-02-25 | 2005-01-19 | Upjohn Co | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados |
| SI1527050T1 (sl) * | 2002-07-25 | 2010-08-31 | Janssen Pharmaceutica Nv | Kinolinski derivati in njihova uporaba kot mikobakterijski inhibitorji |
-
2005
- 2005-12-05 EE EEP200500033A patent/EE05394B1/xx unknown
- 2005-12-06 CA CA2529265A patent/CA2529265C/en not_active Expired - Lifetime
- 2005-12-07 PA PA20058654801A patent/PA8654801A1/es unknown
- 2005-12-07 AU AU2005242138A patent/AU2005242138B2/en not_active Expired
- 2005-12-07 MY MYPI20055732A patent/MY145845A/en unknown
- 2005-12-08 WO PCT/EP2005/056594 patent/WO2006067048A1/en not_active Ceased
- 2005-12-08 US US11/296,992 patent/US20060142279A1/en not_active Abandoned
- 2005-12-08 AP AP2007004054A patent/AP2327A/xx active
- 2005-12-08 TW TW094143290A patent/TWI404535B/zh not_active IP Right Cessation
- 2005-12-08 ME MEP-2011-92A patent/ME01207B/me unknown
- 2005-12-08 PL PL05815816T patent/PL1830850T3/pl unknown
- 2005-12-08 CN CN201210507318.XA patent/CN103142595B/zh not_active Expired - Fee Related
- 2005-12-08 AT AT05815816T patent/ATE501721T1/de active
- 2005-12-08 SI SI200531294T patent/SI1830850T1/sl unknown
- 2005-12-08 RS RS20110221A patent/RS51730B/sr unknown
- 2005-12-08 PT PT05815816T patent/PT1830850E/pt unknown
- 2005-12-08 BR BRPI0506400A patent/BRPI0506400B8/pt not_active IP Right Cessation
- 2005-12-08 HR HR20110392T patent/HRP20110392T1/hr unknown
- 2005-12-08 TR TR2005/04892A patent/TR200504892A1/xx unknown
- 2005-12-08 EP EP05815816A patent/EP1830850B1/en not_active Expired - Lifetime
- 2005-12-08 DK DK05815816.3T patent/DK1830850T3/da active
- 2005-12-08 NZ NZ555460A patent/NZ555460A/en not_active IP Right Cessation
- 2005-12-08 DE DE602005026984T patent/DE602005026984D1/de not_active Expired - Lifetime
- 2005-12-09 LV LVP-05-161A patent/LV13469B/lv unknown
- 2005-12-09 AR ARP050105140A patent/AR051790A1/es unknown
-
2007
- 2007-06-05 NI NI200700146A patent/NI200700146A/es unknown
- 2007-06-21 IL IL184123A patent/IL184123A/en active IP Right Grant
- 2007-07-20 CR CR9267A patent/CR9267A/es not_active Application Discontinuation
- 2007-07-23 NO NO20073823A patent/NO340376B1/no unknown
-
2011
- 2011-06-15 CY CY20111100563T patent/CY1112247T1/el unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO342701B1 (no) * | 2005-06-28 | 2018-07-09 | Janssen Pharmaceutica Nv | Kinolinderivater som antibakterielle midler |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200637551A (en) | Treatment of latent tuberculosis | |
| NO20080955L (no) | Kinolinderivater som antibakterielle midler | |
| NO20081026L (no) | Kinolinderivater som antibakterielle midler | |
| NO20080499L (no) | Kinolinderivater som antibakterielle midler | |
| NO20081068L (no) | Kinolinderivater som antibakterielle midler | |
| NO20080501L (no) | Kinolinderivater som antibakterielle midler | |
| EA200601363A1 (ru) | Замещённые хинолины и их применение в качестве микобактериальных ингибиторов | |
| JO2695B1 (en) | Treatment of latent TB | |
| NO20080481L (no) | Kinolinderivater som antibakterielle midler | |
| TH80291A (th) | การรักษาวัณโรคแฝง |